Depomed Announces Third Quarter 2017 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/7/2026

1. MRVL
2. ZS
3. PENG
4. STZ
5. SKYD
6. BBIO
7. SPY
8. RCKT
9. CRWV
10. NVDA

Go back to Depomed Announces Third Quarter 2017 Financial Results

DepoMed Inc (DEPO) PT Lowered to $6 at RBC Capital Following 3Q Miss

November 8, 2017 8:13 AM EST

RBC Capital lowered its price target on DepoMed Inc (NASDAQ: DEPO) to $6.00 (from $8.00) while maintaining a Sector Perform rating. DEPO reported a 3Q top-line miss and another 2017E guidance step-down. Revenue came in at ~$95 million, below consensus of ~$99 million. Guidance was again lowered by $2030 million to... More

Depomed (DEPO) Tops Q3 EPS by 3c, Revenue Comes in Light

November 7, 2017 4:22 PM EST

Depomed (NASDAQ: DEPO) reported Q3 EPS of $0.14, $0.03 better than the analyst estimate of $0.11. Revenue for the quarter came in at $95 million versus the consensus estimate of $99.57 million.

GUIDANCE:

Depomed sees FY2017 revenue of $375-380 million, versus the consensus of $393.6... More